Phase
Condition
Female Hormonal Deficiencies/abnormalities
Infertility
Perimenopause
Treatment
Transvaginal ultrasound
Ovarian puncture
Hormonal blood Test
Clinical Study ID
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed and dated informed consent
Women 40 years of age and younger with documented primary ovarian insufficiency (12).
Normal Karyotype
BMI </= 35 kg/m2
Oligo/amenorrhea for at least 4 months
FSH > 25 IU/mL
AMH </= 0,1 ng/ml
No evidence of follicles > 4mm
Must have two ovaries of approximately equal volume.
Willingness to undergo further fertility treatment, including IVF if there isevidence of response
A transvaginal scan including Doppler for arteria ovarica will be performedpreviously to the surgical procedure.
Exclusion
Exclusion Criteria:
Premature ovarian failure due to a genetic origin, such as Turner's Syndrome orchromosomal abnormality.
Oncological diseases (specially, skeletal system and blood).
Autoimmune diseases, for example, lupus erythematosus, etc.
Previous treatments including radiotherapy or chemotherapy.
Other conditions not suitable for surgical procedures and/or anesthesia.
Anticoagulant or antiaggregant treatment.
Acute and chronic infectious diseases.
Active substance abuse or dependence.
Major Mental health disorder.
Study Design
Study Description
Connect with a study center
ART Fertility Clinics LLC
Abu Dhabi, 60202
United Arab EmiratesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.